NCT00652886View on ClinicalTrials.gov

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2005

Study Completion Date

June 30, 2005

Conditions
To Determine the Bioequivalence Under Fasting Conditions
Interventions
DRUG

Oxandrolone

Tablets, 10mg, single-dose

DRUG

Oxandrin

tablets, 10mg, single-dose

Trial Locations (1)

63301

Gateway Medical Research, Inc, Saint Charles

Sponsors
All Listed Sponsors
collaborator

Cetero Research, San Antonio

NETWORK

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00652886 - Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter